1 December 2002 in British Journal of Pharmacology
Asthma research is arguably limited by an absence of appropriate animal models to study the pharmacology of inflammatory mediators that affect airway hyperresponsiveness and remodelling. Here we assessed an assay based on mouse tracheal segments cultured for 1–32 days, and investigated contractile responses mediated by muscarinic and 5‐hydroxytryptamine (5‐HT) receptors following long‐term exposure to tumour necrosis factor‐alpha (TNFα). Following culture, in the absence of TNFα, maximum contractile responses to KCl and carbachol were similar, with an increase in response up to day two and a decrease to a stable level after 8 days. Maximal relaxations to isoprenaline were not affected by the culture procedure. The potency of KCl and isoprenaline increased throughout the study. DNA microarray data revealed that global gene expression changes were greater when tissues were introduced to culture than when they were maintained in culture. The morphology of smooth muscle cells was maintained throughout the culture period. 5‐HT induced a weak contraction in both fresh and cultured (up to 8 days) segments. Culture with TNFα produced a time‐ and concentration‐dependent increase in the maximal contraction to 5‐HT, evidently mediated by 5‐HT2A receptors, whereas, the potency for carbachol was reduced. In conclusion, the phenotype of airway smooth muscle remained largely intact during the culture period, even though minor changes were obtained during the first days of culture. The time‐dependent effect of TNFα indicates the importance of studying the long‐term effect of cytokines on the smooth muscle cells in relation to airway hyperresponsiveness and remodelling. British Journal of Pharmacology (2002) 137, 971–982. doi:10.1038/sj.bjp.0704928
1 May 2013 in Pharmacological Research
20 August 2008 in Toxicological Sciences
Cigarette smoke is a strong risk factor for cardiovascular disease. However, the underlying molecular mechanisms that lead to cigarette smoke–associated cardiovascular disease remain elusive. With functional and molecular methods, we demonstrate for the first time that lipid-soluble cigarette smoke particles (dimethylsulfoxide-soluble cigarette smoke particles; DSP) increased the expression of endothelin type B (ETB) receptors in arterial smooth muscle cells. The increased ETB receptors in arterial smooth muscle cells was documented as enhanced contractility (sensitive myograph technique), elevated levels of ETB receptor mRNA (quantitative real-time PCR), and protein expressions (immunohistochemistry and Western blotting). Intracellular signaling was studied with Western blotting and phosphoELISA; this revealed that DSP induced extracellular-regulated protein kinases 1 and 2 (ERK1/2), p38, and nuclear factor–kappaB (NF-κB) phosphorylation within 3 h. Blocking ERK1/2, p38, or NF-κB activation by their specific inhibitors significantly attenuated the DSP-induced upregulation of ETB receptor–mediated contraction and both ETB receptor mRNA and protein expression. In addition, dexamethasone abolished the DSP-induced upregulation of ETB receptor–mediated contraction. In conclusion, upregulation of ETB receptors by DSP in arterial smooth muscle cells involves activation of mitogen-activating protein kinases (ERK1/2 and p38) and the downstream transcriptional factor NF-κB pathways.
1 April 2004 in European Journal of Pharmacology
2 April 2007 in Respiratory Research
Interleukin 1 beta (IL-1β) is found in bronchoalveolar lavage fluids from asthmatic patients and plays an important role in normal immunoregulatory processes but also in pathophysiological inflammatory responses. The present study was designed to investigate if IL-1β could be involved in the development of airway hyperresponsiveness and if transcriptional mechanisms, epithelium contractile factors and mitogen-activated protein kinase (MAPK) pathways are involved in IL-1β effect.
1 June 2007 in American Journal of Respiratory Cell and Molecular Biology
Hyperresponsiveness to bronchoconstrictor stimuli is a major pathophysiologic feature of asthma, but the molecular mechanisms behind this are not fully understood. The release of TNF-α and IL-1β during the inflammatory process is believed to play an important role in airway hyperresponsiveness. We have previously demonstrated, using a murine in vitro model of chronic airway inflammation, that TNF-α up-regulated bradykinin B1 and B2 receptors in the airway smooth muscle. By using the same model, the present study was designed to investigate the effects of IL-1β and its interaction with TNF-α on the expression of bradykinin B1 and B2 receptors in mouse tracheal smooth muscle. IL-1β up-regulated bradykinin B1 and B2 receptor expression and increased contractile response to bradykinin B1 and B2 receptor agonists (des-Arg9-bradykinin and bradykinin, respectively) in the tracheal smooth muscle. Transcriptional inhibitor actinomycin D, c-Jun N-terminal kinase (JNK) inhibitors SP600125 and TAT-TI-JIP153–163, but not extracellular signal–regulated kinase 1 and 2 (ERK 1/2) inhibitor PD98059, significantly attenuated this up-regulation, indicating that a transcriptional mechanism and intracellular JNK signal transduction pathway were involved. In addition, IL-1β did not affect bradykinin B1 and B2 receptor mRNA stability. Remicade, an anti–TNF-α antibody, markedly suppressed IL-1β–induced up-regulation of bradykinin B1 and B2 receptors, suggesting that TNF-α was involved in the up-regulation, which is further supported by the fact that IL-1β enhanced TNF-α mRNA expression in the tracheae. Intracellular JNK pathway and TNF-α might provide key links between inflammatory mediators like IL-1β and airway hyperresponsiveness to bradykinin.